
City Therapeutics Inc.
CTY | NASDAQ
$21.18
+$0.47 (+2.27%)
Nov 2, 2026, 11:50 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2020 Jun 30, 2020 | Q1 2020 Mar 31, 2020 | Q4 2019 Dec 31, 2019 | Q3 2019 Sep 30, 2019 | Q2 2019 Jun 30, 2019 | Q1 2019 Mar 31, 2019 | Q4 2018 Dec 31, 2018 | Q3 2018 Sep 30, 2018 | Q2 2018 Jun 30, 2018 | Q1 2018 Mar 31, 2018 | Q4 2017 Dec 31, 2017 | Q3 2017 Sep 30, 2017 | Q2 2017 Jun 30, 2017 | Q1 2017 Mar 31, 2017 | Q4 2016 Dec 31, 2016 | Q3 2016 Sep 30, 2016 | Q2 2016 Jun 30, 2016 | Q1 2016 Mar 31, 2016 | Q4 2015 Dec 31, 2015 | Q3 2015 Sep 30, 2015 | Q2 2015 Jun 30, 2015 | Q1 2015 Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 524M | 1.92B | 2.01B | 2.04B | 2.05B | 2.06B | 2.11B | 2.15B | 2.1B | 2.13B | 2.11B | 2.14B | 2.13B | 2.16B | 2.21B | 2.23B | 2.22B | 2.25B | 2.24B | 2.29B | 2.22B | 2.22B |
Cost of Revenue | 490M | 473M | 613M | 630M | 588M | 607M | 661M | 697M | 702M | 707M | 696M | 742M | 723M | 720M | 738M | 757M | 731M | 708M | 703M | 734M | 743M | 692M |
Gross Profit | 34M | 1.45B | 1.4B | 1.41B | 1.46B | 1.45B | 1.45B | 1.45B | 1.4B | 1.42B | 1.42B | 1.4B | 1.41B | 1.44B | 1.47B | 1.47B | 1.49B | 1.55B | 1.54B | 1.55B | 1.48B | 1.53B |
Operating Income | 679M | 779M | 626M | 748M | 750M | 760M | 685M | 717M | 626M | 632M | 600M | 560M | 573M | 580M | 519M | 576M | 602M | 625M | 622M | 572M | 521M | 545M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 583M | 680M | 523M | 643M | 644M | 658M | 577M | 564M | 508M | 510M | 468M | 433M | 438M | 452M | 390M | 414M | 467M | 492M | 490M | 439M | 390M | 414M |
Net Income | 430M | 503M | 386M | 477M | 477M | 487M | 405M | 453M | 427M | 380M | 846M | 265M | 268M | 278M | 238M | 255M | 288M | 304M | 321M | 268M | 238M | 247M |
Selling & General & Admin | 139M | 143M | -3.23B | 1.29B | 1.3B | 1.3B | 1.43B | 1.43B | 1.48B | 1.5B | 1.51B | 1.58B | 1.56B | 1.58B | 1.69B | 1.65B | 1.62B | 1.63B | 1.62B | 1.72B | 1.7B | 1.67B |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 139M | 143M | -3.23B | 1.29B | 1.3B | 1.3B | 1.43B | 1.43B | 1.48B | 1.5B | 1.51B | 1.58B | 1.56B | 1.58B | 1.69B | 1.65B | 1.62B | 1.63B | 1.62B | 1.72B | 1.7B | 1.67B |
Interest Expense | n/a | n/a | -286M | 95M | 96M | 95M | 98M | 112M | 120M | 118M | 117M | 117M | 117M | 114M | 116M | 121M | 120M | 121M | 117M | 119M | 119M | 118M |
Selling & Marketing Expenses | n/a | n/a | n/a | 1.16B | 1.14B | 1.14B | 1.23B | 1.26B | 1.26B | 1.28B | 1.3B | 1.35B | 1.33B | 1.34B | 1.38B | 1.42B | 1.39B | 1.38B | 1.39B | 1.45B | 1.45B | 1.4B |
Cost & Expenses | 1.12B | 1.14B | 1.39B | 1.92B | 1.89B | 1.9B | 2.09B | 2.13B | 2.18B | 2.21B | 2.21B | 2.32B | 2.28B | 2.3B | 2.43B | 2.41B | 2.35B | 2.34B | 2.32B | 2.45B | 2.44B | 2.36B |
Income Tax Expense | 153M | 177M | 137M | 166M | 167M | 171M | 172M | 111M | 81M | 130M | -378M | 168M | 170M | 174M | 152M | 159M | 179M | 188M | 169M | 171M | 152M | 167M |
Shares Outstanding (Basic) | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Diluted) | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EPS (Basic) | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EPS (Diluted) | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA | 910M | 1.01B | 584M | 1.08B | 1.08B | 1.09B | 1.03B | 1.04B | 989M | 988M | 985M | 947M | 950M | 955M | 926M | 958M | 1.01B | 1.03B | 1.07B | 1.02B | 968M | 988M |
EBIT | n/a | n/a | 237M | 738M | 740M | 753M | 675M | 676M | 628M | 628M | 585M | 550M | 555M | 566M | 506M | 535M | 587M | 613M | 607M | 558M | 509M | 532M |
Depreciation & Amortization | 327M | 328M | 347M | 344M | 337M | 336M | 356M | 360M | 361M | 360M | 400M | 397M | 395M | 389M | 420M | 423M | 421M | 415M | 462M | 462M | 459M | 456M |
Add to Watchlist
Select watchlists to add or remove CTY